Breaking News, Financial News

Financial Report: Allergan 3Q13

Revenues up 13% in the quarter

Allergan

3Q Revenues: $1.6 billion (+13%)

3Q Earnings: $300.8 million (+20%)

YTD Revenues: $4.6 billion (+11%)

YTD Earnings: $676.4 million (-13%)

Comments: Specialty pharmaceuticals sales were $1.3 billion in the quarter, up 13%. Eye Care Pharmaceuticals sales were $717.1 million, up 8%. Botox/Neuromodulators sales were $485.7 million, up 13%. Medical devices sales increased 13% to $198.6 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters